A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokines - Marriott,J.B.; Cookson,S.; Carlin,E. (AIDS Res Human Retroviruses, 1997)